Rong Du

1.4k total citations
33 papers, 550 citations indexed

About

Rong Du is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rong Du has authored 33 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Rong Du's work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Rong Du is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Rong Du collaborates with scholars based in China, United States and Canada. Rong Du's co-authors include Yan Ding, Yuejie Zhu, Fei Ji, Jianbing Ding, Nannan Pang, Zhifang Chen, Meng Zhang, Yan Ding, Tianfeng Chen and Xin Luo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rong Du

33 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Du China 14 249 163 153 129 74 33 550
Beibei Ni China 15 480 1.9× 186 1.1× 133 0.9× 104 0.8× 65 0.9× 33 740
Xipeng Zhang China 14 293 1.2× 213 1.3× 160 1.0× 81 0.6× 42 0.6× 38 572
Di Xiang China 15 284 1.1× 101 0.6× 132 0.9× 102 0.8× 46 0.6× 27 559
Jiazhang Wei China 14 324 1.3× 194 1.2× 126 0.8× 94 0.7× 39 0.5× 46 606
Jianming Huang China 13 211 0.8× 128 0.8× 106 0.7× 90 0.7× 41 0.6× 41 450
Yuexin Lu China 10 234 0.9× 88 0.5× 118 0.8× 98 0.8× 144 1.9× 21 537
Caroline Contat Switzerland 5 381 1.5× 274 1.7× 169 1.1× 222 1.7× 44 0.6× 5 715
Yihang Gong China 11 179 0.7× 123 0.8× 131 0.9× 130 1.0× 58 0.8× 23 461
Ju Ma China 13 297 1.2× 189 1.2× 101 0.7× 53 0.4× 55 0.7× 19 487

Countries citing papers authored by Rong Du

Since Specialization
Citations

This map shows the geographic impact of Rong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Du more than expected).

Fields of papers citing papers by Rong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Du. The network helps show where Rong Du may publish in the future.

Co-authorship network of co-authors of Rong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Du. A scholar is included among the top collaborators of Rong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Du. Rong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaojing, Rong Du, Zhiqian Yu, et al.. (2024). Naringenin inhibits APAP-induced acute liver injury through activating PPARA-dependent signaling pathway. Experimental Cell Research. 437(2). 114028–114028. 1 indexed citations
2.
Chen, Xiaojing, Zhiqian Yu, Rong Du, et al.. (2023). Progress of research on the role of active ingredients of Citri Reticulatae Pericarpium in liver injury. Phytomedicine. 115. 154836–154836. 31 indexed citations
3.
Xu, Yanhua, Mu Zhang, Qin Shi, et al.. (2023). Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis. European journal of medical research. 28(1). 79–79. 4 indexed citations
4.
Xu, Weiguo, et al.. (2022). The Prognostic Role of Chronic Obstructive Pulmonary Disease for Lung Cancer After Pulmonary Resection. Journal of Surgical Research. 275. 137–148. 7 indexed citations
5.
Woo, Seung‐Hyun, Junya Zhang, Jianli Gong, et al.. (2022). Tbc1d10c is a selective, constitutive suppressor of the CD8 T-cell anti-tumor response. OncoImmunology. 11(1). 2141011–2141011. 4 indexed citations
6.
Du, Rong, et al.. (2021). The CD200–CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Cancer Research. 81(19). 5021–5032. 20 indexed citations
7.
Du, Rong, Delaney K. Sullivan, Nancy G. Azizian, Liu Y, & Yulin Li. (2021). Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells. BMC Cancer. 21(1). 237–237. 18 indexed citations
8.
Zong, Hao, et al.. (2020). The complete mitochondrial genome of Pseudoxenodon macrops. SHILAP Revista de lepidopterología. 5(2). 1473–1474. 1 indexed citations
9.
Zhu, Yuejie, Rong Du, Nannan Pang, et al.. (2019). Role of Regulatory B Cells in the Progression of Cervical Cancer. Mediators of Inflammation. 2019. 1–8. 44 indexed citations
10.
Ji, Fei, Rong Du, Tianfeng Chen, et al.. (2019). Circular RNA circSLC26A4 Accelerates Cervical Cancer Progression via miR-1287-5p/HOXA7 Axis. Molecular Therapy — Nucleic Acids. 19. 413–420. 87 indexed citations
11.
Zhang, Linshi, Jiarong Zhou, Yingcai Yan, et al.. (2019). Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xenografts. Cancer Letters. 465. 36–44. 7 indexed citations
12.
Du, Rong, et al.. (2019). Identification of pelvic organ prolapse risk susceptibility gene SNP locus in Xinjiang women. International Urogynecology Journal. 31(1). 123–130. 12 indexed citations
13.
Zhang, Yu, Guannan Guo, Ben Ma, et al.. (2015). A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting. Anti-Cancer Drugs. 26(7). 698–705. 19 indexed citations
14.
Luo, Yumei, Detu Zhu, Rong Du, et al.. (2015). Uniparental disomy of the entire X chromosome in Turner syndrome patient-specific induced pluripotent stem cells. Cell Discovery. 1(1). 15022–15022. 21 indexed citations
15.
Du, Rong, Haihua Xiao, Guannan Guo, et al.. (2014). Nanoparticle delivery of photosensitive Pt(IV) drugs for circumventing cisplatin cellular pathway and on-demand drug release. Colloids and Surfaces B Biointerfaces. 123. 734–741. 31 indexed citations
16.
Chen, Zhifang, Jianbing Ding, Nannan Pang, et al.. (2013). The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagnostic Pathology. 8(1). 61–61. 56 indexed citations
17.
Chen, Zhifang, Wei Meng, Rong Du, et al.. (2013). Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China. Experimental and Therapeutic Medicine. 6(1). 85–90. 12 indexed citations
18.
Zhu, Jinzhou, Jing Zhang, Ke Yang, et al.. (2012). P-cresol, but not p-cresylsulphate, disrupts endothelial progenitor cell function in vitro. Nephrology Dialysis Transplantation. 27(12). 4323–4330. 20 indexed citations
19.
Tian, Li, et al.. (2008). [Gene mutation in secundum atrial septal defect: analysis of a Chinese family with 3 patients].. PubMed. 88(4). 250–3. 2 indexed citations
20.
Yang, Hong, et al.. (2003). Phenotypes of transgenic tomato with antisense LeETR2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026